Noninvasive biomarkers in non-alcoholic fatty liver disease: Current status and a glimpse of the future

Figure 1 Serum biomarkers of disease activity may measure inflammation, apoptosis, oxidative stress or fibrosis. This is a schematic representation of the pathophysiological processes in nonalcoholic fatty liver disease (NAFLD), markers of which may be demonstrable in serum. LDL: Low density lipoprotein; IL: Interleukin; TBARS: Thiobarbituric acid reactive substances; TIMP1: Tissue inhibitor of MMP 1.

Figure 2 An approach to using noninvasive markers of disease to assess severity of disease in nonalcoholic fatty liver disease.